Globe and Mail: Editorial supports MS clinical trials

An editorial in the Globe and Mail about Canada's decision to participate in clinical trials of a potentially revolutionary treatment for multiple sclerosis notes a UB study casts doubt on the theory that vein blockages contribute to the disease, but the authors of that study also said, "It behooves the clinical research community to carefully pursue [the theory] to its end. We should neither jump on the bandwagon as it passes through town, nor assiduously miss the parade." An article in the Toronto Star also looks at UB's study.